These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16283214)

  • 41. Treatment of native valve Candida endocarditis with fluconazole.
    Wells CJ; Leech GJ; Lever AM; Wansbrough-Jones MH
    J Infect; 1995 Nov; 31(3):233-5. PubMed ID: 8586845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term suppressive therapy for Candida parapsilosis-induced prosthetic valve endocarditis.
    Baddour LM
    Mayo Clin Proc; 1995 Aug; 70(8):773-5. PubMed ID: 7630216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Endocarditis due to Candida glabrata on a prosthetic valve].
    Sastre Rincón JA; Dalmau Sorli MJ; López Correa T
    Rev Esp Anestesiol Reanim; 2012; 59(6):345. PubMed ID: 22542877
    [No Abstract]   [Full Text] [Related]  

  • 44. Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans.
    Bland CM; Thomas S
    Ann Pharmacother; 2009 Mar; 43(3):528-31. PubMed ID: 19261955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caspofungin versus amphotericin B for invasive candidiasis.
    Brown AL; Greig JR
    N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
    [No Abstract]   [Full Text] [Related]  

  • 47. Candida tropicalis causing prosthetic valve endocarditis.
    Nagaraja PA; Mathew T; Shetty DP
    Indian J Med Microbiol; 2005 Apr; 23(2):139-40. PubMed ID: 15928449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
    Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
    Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection.
    Schelenz S; Ross CN
    BMC Infect Dis; 2006 Aug; 6():126. PubMed ID: 16895593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient.
    Arend SM; Kuijper EJ; de Vaal BJ; de Fijter JW; van't Wout JW
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):43-5. PubMed ID: 16365722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis.
    Muehrcke DD; Lytle BW; Cosgrove DM
    Ann Thorac Surg; 1995 Sep; 60(3):538-43. PubMed ID: 7677477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.
    MacCallum DM; Odds FC
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4911-4. PubMed ID: 15561880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
    Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE
    Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii.
    Martinez-Lacasa J; Maña J; Niubó R; Rufi G; Saez A; Fernández-Nogués F
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):756-8. PubMed ID: 1810731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata.
    Roger PM; Boissy C; Gari-Toussaint M; Foucher R; Mondain V; Vandenbos F; le Fichoux Y; Michiels JF; Dellamonica P
    J Infect; 2000 Sep; 41(2):176-8. PubMed ID: 11023765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 58. Experience with caspofungin in the treatment of persistent fungemia in neonates.
    Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
    J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.
    Pelletier R; Alarie I; Lagacé R; Walsh TJ
    Med Mycol; 2005 Sep; 43(6):559-64. PubMed ID: 16320498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient.
    Legout L; Assal M; Rohner P; Lew D; Bernard L; Hoffmeyer P
    Scand J Infect Dis; 2006; 38(8):728-30. PubMed ID: 16857628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.